Transgene IL-21-Engineered T Cell-Based Vaccine Potently Converts CTL Exhaustion via the Activation of the mTORC1 Pathway in Chronic Infection
World Journal of Vaccines
doi 10.4236/wjv.2019.91001
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2019
Authors
Publisher
Scientific Research Publishing, Inc,